Literature DB >> 24771894

Cytotoxic T-Cells in Peripheral Blood in Women with Endometriosis.

N Slabe1, H Meden-Vrtovec1, I Verdenik1, R Kosir-Pogacnik1, A Ihan2.   

Abstract

Aim: The etiology of endometriosis remains unknown, but increasing evidence suggests that immune regulation may be important. Our study aimed to evaluate peripheral blood lymphocyte subpopulations during the menstrual cycle in women with peritoneal and ovarian endometriosis relative to healthy women.
Methods: In this study, 65 women with endometriosis (37 in the follicular phase and 28 in the luteal phase of the menstrual cycle) and 61 healthy women (33 in the follicular phase and 28 in the luteal phase) were enrolled. Flow cytometric analysis measured peripheral blood lymphocyte subpopulations. The serum levels of cortisol were also determined.
Results: In healthy controls, we detected an increased concentration of cytotoxic (CD8+) T cells and activated (HLA-DR) T cells in the luteal phase compared with the follicular phase of the menstrual cycle (p = 0.020 and p = 0.045), whereas no such fluctuation was detected in endometriosis. However, a marked increase in regulatory T-cell concentration in the luteal phase was detected only in endometriosis patients (p = 0.005). Women with endometriosis had higher levels of serum cortisol (p = 0.022), which correlated with the concentration of regulatory T cells (p = 0.048). Conclusions: Women with endometriosis do not exhibit fluctuations in the concentrations of cytotoxic and activated peripheral blood lymphocytes during the menstrual cycle. The marked fluctuation of regulatory T cells detected in endometriosis could be attributed to altered immune response.

Entities:  

Keywords:  cell immunity; endometriosis; gynecology; infertility; regulatory T cells

Year:  2013        PMID: 24771894      PMCID: PMC3862048          DOI: 10.1055/s-0033-1350702

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  41 in total

1.  Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation.

Authors:  G Aleph Prieto; Yvonne Rosenstein
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  The diagnosis and treatment of deep infiltrating endometriosis.

Authors:  Gülden Halis; Sylvia Mechsner; Andreas D Ebert
Journal:  Dtsch Arztebl Int       Date:  2010-06-25       Impact factor: 5.594

3.  Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis.

Authors:  Richard O Burney; Said Talbi; Amy E Hamilton; Kim Chi Vo; Mette Nyegaard; Camran R Nezhat; Bruce A Lessey; Linda C Giudice
Journal:  Endocrinology       Date:  2007-05-17       Impact factor: 4.736

4.  Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome.

Authors:  R Matorras; I Ocerin; M Unamuno; A Nieto; E Peiró; J Burgos; A Expósito
Journal:  Lupus       Date:  2007       Impact factor: 2.911

5.  Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction.

Authors:  Lourdes Arruvito; Marianela Sanz; Alison H Banham; Leonardo Fainboim
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

6.  Increased expression of interleukin-1 receptor type 1 in active endometriotic lesions.

Authors:  C Lawson; M Al-Akoum; R Maheux; A Akoum
Journal:  Reproduction       Date:  2007-01       Impact factor: 3.906

7.  CD4⁺ CD25⁺ FOXP3⁺ regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis.

Authors:  Joanna Olkowska-Truchanowicz; Katarzyna Bocian; Radosław B Maksym; Agata Białoszewska; Dariusz Włodarczyk; Włodzimierz Baranowski; Jakub Ząbek; Grażyna Korczak-Kowalska; Jacek Malejczyk
Journal:  Hum Reprod       Date:  2012-09-27       Impact factor: 6.918

8.  Prolactin and cortisol levels in women with endometriosis.

Authors:  A P Lima; M D Moura; A A M Rosa e Silva
Journal:  Braz J Med Biol Res       Date:  2006-08       Impact factor: 2.590

Review 9.  Endometriotic disease: the role of peritoneal fluid.

Authors:  P R Koninckx; S H Kennedy; D H Barlow
Journal:  Hum Reprod Update       Date:  1998 Sep-Oct       Impact factor: 15.610

10.  Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis.

Authors:  P Viganò; P Vercellini; A M Di Blasio; A Colombo; G B Candiani; M Vignali
Journal:  Fertil Steril       Date:  1991-11       Impact factor: 7.329

View more
  9 in total

1.  Endometriosis - A Chameleon: Patients' Perception of Clinical Symptoms, Treatment Strategies and Their Impact on Symptoms.

Authors:  P Wimberger; N Grübling; A Riehn; M Furch; J Klengel; M Goeckenjan
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-10       Impact factor: 2.915

Review 2.  The endometrial immune environment of women with endometriosis.

Authors:  Júlia Vallvé-Juanico; Sahar Houshdaran; Linda C Giudice
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

3.  Immune-inflammation gene signatures in endometriosis patients.

Authors:  Soo Hyun Ahn; Kasra Khalaj; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade
Journal:  Fertil Steril       Date:  2016-07-27       Impact factor: 7.329

4.  Diagnostic gene biomarkers for predicting immune infiltration in endometriosis.

Authors:  Chengmao Xie; Chang Lu; Yong Liu; Zhaohui Liu
Journal:  BMC Womens Health       Date:  2022-05-18       Impact factor: 2.742

Review 5.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

6.  Endometriosis: Survey of Current Diagnostic and Therapeutic Options and Latest Research Work.

Authors:  I Juhasz-Böss; M W Laschke; F Müller; P Rosenbaum; S Baum; E F Solomayer; U Ulrich
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-08       Impact factor: 2.915

Review 7.  Epigenetic regulation and T-cell responses in endometriosis - something other than autoimmunity.

Authors:  Dariusz Szukiewicz
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

8.  Tofacitinib alters STAT3 signaling and leads to endometriosis lesion regression.

Authors:  Alexander M Kotlyar; Ramanaiah Mamillapalli; Valerie A Flores; Hugh S Taylor
Journal:  Mol Hum Reprod       Date:  2021-03-24       Impact factor: 4.025

Review 9.  Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis.

Authors:  Elizabeth García-Gómez; Edgar Ricardo Vázquez-Martínez; Christian Reyes-Mayoral; Oliver Paul Cruz-Orozco; Ignacio Camacho-Arroyo; Marco Cerbón
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-29       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.